Literature DB >> 32441815

Scalable, two-stage, autoinduction of recombinant protein expression in E. coli utilizing phosphate depletion.

Romel Menacho-Melgar1, Zhixia Ye1, Eirik A Moreb1, Tian Yang1, John P Efromson1, John S Decker1, Ruixin Wang1, Michael D Lynch1.   

Abstract

We report the scalable production of recombinant proteins in Escherichia coli, reliant on tightly controlled autoinduction, triggered by phosphate depletion in the stationary phase. The method, reliant on engineered strains and plasmids, enables improved protein expression across scales. Expression levels using this approach have reached as high as 55% of the total cellular protein. The initial use of the method in instrumented fed-batch fermentations enables cell densities of ∼30 gCDW/L and protein titers up to 8.1 ± 0.7 g/L (∼270 mg/gCDW). The process has also been adapted to an optimized autoinduction media, enabling routine batch production at culture volumes of 20 μl (384-well plates), 100 μl (96-well plates), 20 ml, and 100 ml. In batch cultures, cell densities routinely reach ∼5-7 gCDW/L, offering protein titers above 2 g/L. The methodology has been validated with a set of diverse heterologous proteins and is of general use for the facile optimization of routine protein expression from high throughput screens to fed-batch fermentation.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  autoinduction; phosphate depletion; protein expression; stationary phase

Year:  2020        PMID: 32441815     DOI: 10.1002/bit.27440

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Simple Scalable Protein Expression and Extraction Using Two-stage Autoinducible Cell Autolysis and DNA/RNA Autohydrolysis in Escherichia coli.

Authors:  Romel Menacho-Melgar; Michael D Lynch
Journal:  Bio Protoc       Date:  2022-01-20

2.  Decoupling Growth and Production by Removing the Origin of Replication from a Bacterial Chromosome.

Authors:  Marje Kasari; Villu Kasari; Mirjam Kärmas; Arvi Jõers
Journal:  ACS Synth Biol       Date:  2022-07-07       Impact factor: 5.249

3.  Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate.

Authors:  John S Decker; Romel Menacho-Melgar; Michael D Lynch
Journal:  Biochem Eng J       Date:  2022-03-12       Impact factor: 3.978

Review 4.  Strategies for Glycoengineering Therapeutic Proteins.

Authors:  Kris Dammen-Brower; Paige Epler; Stanley Zhu; Zachary J Bernstein; Paul R Stabach; Demetrios T Braddock; Jamie B Spangler; Kevin J Yarema
Journal:  Front Chem       Date:  2022-04-13       Impact factor: 5.545

Review 5.  Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity.

Authors:  Zi-Xu Zhang; Fang-Tong Nong; Yu-Zhou Wang; Chun-Xiao Yan; Yang Gu; Ping Song; Xiao-Man Sun
Journal:  Microb Cell Fact       Date:  2022-09-15       Impact factor: 6.352

6.  Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin.

Authors:  John S Decker; Romel Menacho-Melgar; Michael D Lynch
Journal:  Front Bioeng Biotechnol       Date:  2020-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.